Cargando…
Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart
Diabetes is a chronic, endocrine disorder that effects millions of people worldwide. Cardiovascular complications are the major cause of diabetes-related morbidity and mortality. Cardiac β(1)- and β(2)-adrenoceptor (AR) stimulation mediates positive inotropy and chronotropy, whereas β(3)-AR mediates...
Autores principales: | Erdogan, Betul R., Michel, Martin C., Arioglu-Inan, Ebru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759850/ https://www.ncbi.nlm.nih.gov/pubmed/33256212 http://dx.doi.org/10.3390/cells9122548 |
Ejemplares similares
-
Established and emerging treatments for diabetes-associated lower urinary tract dysfunction
por: Erdogan, Betül R., et al.
Publicado: (2022) -
Effects of sitagliptin on ß-adrenoceptor mediated relaxation in streptozotocin-diabetic rat aorta
por: MÜDERRİSOĞLU, Ayhanım Elif, et al.
Publicado: (2021) -
Cardiac and Vascular α(1)-Adrenoceptors in Congestive Heart Failure: A Systematic Review
por: Kaykı-Mutlu, Gizem, et al.
Publicado: (2020) -
Decreased expression of β(1)- and β(2)-adrenoceptors in human diabetic atrial appendage
por: Dinçer, U Deniz, et al.
Publicado: (2003) -
A comparison of urinary bladder weight in male and female mice across five models of diabetes and obesity
por: Erdogan, Betül R., et al.
Publicado: (2023)